LivaNova (LIVN) Total Debt (2015 - 2026)
LivaNova's (LIVN) quarterly Total Debt came in at $287.8 million in Q1 2026, down 54.23% year-on-year from $628.8 million in Q1 2025, and down 23.59% quarter-over-quarter from $376.7 million in Q4 2025.
LivaNova (LIVN) Total Debt (2015 - 2026) Analysis & Trends
LivaNova has disclosed Total Debt across 12 years of filings, most recently posting $287.8 million for Q1 2026.
- Total Debt for Q1 2026 came in at $287.8 million, down 54.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $287.8 million (down 54.23% YoY), and the FY2025 annual result was $376.7 million, down 39.99% from the prior year.
- Total Debt came in at $287.8 million for Q1 2026 at LivaNova, down from $376.7 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $628.8 million in Q1 2025 to a low of $287.8 million in Q1 2026.
- The 5-year median for Total Debt is $542.5 million (2023), against an average of $525.7 million.
- Across the five-year window, Total Debt soared 232.92% in 2022 and plunged 54.23% in 2026, its largest moves.
- LivaNova's Total Debt stood at $541.5 million in 2022, then increased by 8.34% to $586.7 million in 2023, then increased by 6.98% to $627.6 million in 2024, then tumbled by 39.99% to $376.7 million in 2025, then fell by 23.59% to $287.8 million in 2026.
- The last three Total Debt figures came in at $287.8 million (Q1 2026), $376.7 million (Q4 2025), and $434.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 34.05 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.72 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 28.07 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 11.03 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.48 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.93 Bn |
| 10 | LivaNova | 4.29 Bn | 3.71 Bn | 243.75 Mn | 287.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 287.79 Mn |
| Dec 31, 2025 | 376.66 Mn |
| Sep 30, 2025 | 434.47 Mn |
| Jun 30, 2025 | 396.75 Mn |
| Mar 31, 2025 | 628.79 Mn |
| Dec 31, 2024 | 627.63 Mn |
| Sep 30, 2024 | 626.24 Mn |
| Jun 30, 2024 | 625.17 Mn |
| Mar 31, 2024 | 624.46 Mn |
| Dec 31, 2023 | 586.65 Mn |
| Sep 30, 2023 | 587.19 Mn |
| Jun 30, 2023 | 587.03 Mn |
| Mar 31, 2023 | 542.50 Mn |
| Dec 31, 2022 | 541.50 Mn |
| Sep 30, 2022 | 539.94 Mn |
| Jun 30, 2022 | 466.03 Mn |
| Mar 31, 2022 | 457.74 Mn |
| Dec 31, 2021 | 192.96 Mn |
| Sep 30, 2021 | 162.19 Mn |
| Jun 30, 2021 | 605.90 Mn |